Effect of topiramate on sweat chloride level while screening for cystic fibrosis

Research output: Contribution to journalArticle

Abstract

Cystic fibrosis is the most common life-limiting genetic condition in Caucasians caused by Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene mutations. Sweat chloride is the current gold standard for diagnosis where values >60 mmol/L are diagnostic and values >30 mmol/L are indeterminate. There is limited literature on the effect of medications on the sweat chloride values. We report a case of topiramate being responsible for false-positive testing which resulted in overutilisation of medical resources and psychosocial stress on the family. Topiramate should be considered during the interpretation of the gold standard testing as one of the cause of false-positive sweat tests.

Original languageEnglish (US)
Article number225697
JournalBMJ Case Reports
Volume2018
DOIs
StatePublished - Jan 1 2018

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Effect of topiramate on sweat chloride level while screening for cystic fibrosis'. Together they form a unique fingerprint.

  • Cite this